The Latest

Whether you're a patient, clinician, retailer or researcher, come with us as we work to bring quality, accessible cannabis care (and data) to all.

Featured

News

EO Care Appoints William Fleming and Kristi Savacool to Board of Directors

March 11, 2026

EO Team

EO Care has appointed healthcare leaders William Fleming (former Humana executive) and Kristi Savacool (former Aon Hewitt CEO) to its Board of Directors, strengthening governance as cannabinoid-based symptom management enters mainstream healthcare.

News

EO Data & Methodology: November 2025 Update

At EO, we systematically track how patients feel and function after starting guided cannabis care. The data below come from real people using cannabis to manage symptoms such as pain, sleep disturbance, anxiety, and nausea/vomiting, under the guidance of our clinical protocols.

News

EO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data

Meaningful improvements were reported by patients after one (1) week and sustained through four (4) weeks of guided cannabinoid care, particularly among people over 50 and cancer patients. Patients also reported low rates of use-limiting side effects with further reductions after receiving updated recommended product and/or dosing guidance via EO Care’s digital care platform.

News

Living with Chronic Pain

Chronic pain is prevalent. A 2016 report estimates that over 20% of adults in the United States have experienced some form of chronic pain. Of those 50 million Americans, 8% suffer from some form of high impact chronic pain; pain that has lasted over three months and prohibits them from performing important activities in their daily lives.

News

Meet eo: the Future of Cannabis Care

People are suffering. Cannabis offers the potential of relief, but cannabis care today leaves much to be desired in the way of guidance, data, and consistency. eo is a digital therapeutic, telemedicine platform and clinical data source. We are on a mission to deliver the future of cannabis care through personalized, calendar-based care plans and ongoing clinical guidance delivered on an intuitive digital platform.

News

Ingredients for Effective Care

Not all patients are the same. Each person has unique underlying health conditions, personal experiences, and needs. What works for one patient is not guaranteed to work for all. Some patients might be allergic to a specific medication, others might be able to tolerate it but are unable to take it due to incompatible work schedules, and others might be a perfect fit for the same medication.

Events

Community & Cannabis

The right community will grant you the ability to talk about shared experiences, educate yourself from a collective pool of knowledge, and bask in the comfort of knowing that you are not alone. There are communities of support for people who are battling cancer and coping with insomnia, so why shouldn’t there be a place for cannabis patients to gather and enjoy the benefits of community?

News

Gaps in Guidance

Last week, you took an edible to help manage your anxiety after a long work day. The cannabis provided some relief, but since then you haven’t been able to recreate that result. Starting your cannabis journey is daunting, and it can be hard to know where to go for guidance.

Research

CBD & Gastrointestinal Pain

Cannabidiol (CBD) is a component of the plant cannabis with great potential for medical applications because of its proven anti-inflammatory, anti-tumoral, analgesic (pain-relieving), and anxiolytic (anxiety-relieving) properties and its lack of psychological side effects.

News

Cannabinoids & Pain Control

Proponents of cannabis use in a medical context have often suggested that it is a superior substitute of opioid for chronic pain management. Cannabis owes its analgesic properties to components called cannabinoids, with the two most prominent being cannabidiol (CBD) and tetrahydrocannabinol (THC). Both compounds have similar potential for treating chronic pain, however, while THC is addictive, CBD is not and therefore is of special clinical interest.

News

Cannabis & Sleeplessness

If you are having trouble getting a good night’s sleep these days, you’re not alone. Up to 70 million people are affected by sleep disorders, according to data from the National Institutes of Health, and consumers are spending $70 billion a year on sleep aids, 65% of which goes to medications.

Research

CB2 as a Regulator of Anxiety & Potential Target for PTSD Drugs

Researchers recently identified a signaling pathway in the endocannabinoid system that regulates long-lasting anxiety, a central symptom of post-traumatic stress disorder (PTSD). In particular, CB2 - one of the two main endocannabinoid receptors - mediates the response: its activation appears to have an anxiolytic (anxiety reducing) effect while its inhibition an anxiogenic (anxiety inducing) one.

News

The Pros & Cons of Vaporization

Researchers have recently analyzed popular vaping behavior and revealed the advantages of vaporizing medical cannabis. The general advantages of vaporizing medical cannabis include portability, concealability, and efficiency, while the medical advantages like promoting tobacco cessation and it’s quick-acting effects.

News

What Is The Entourage Effect?

Along with THC, the cannabis plant produces over 400 different chemical compounds that include dozens of other cannabinoids like CBD and CBN, and hundreds terpenes like pinene, linalool and myrcene. When the compounds are applied together (whether it’s through smoking, vaping or especially transdermal applications), they work to provide unique effects and benefits.

Events

Cannabis and Men's Health: A CED Clinic Live Webinar

In honor of Men's Health Month, tonight's webinar will focus on the unique differences that men may have when consuming cannabis.Join Dr. Caplan this evening to review the latest cannabis studies that relate to men's sexual, mental and physical health. All are welcome to attend and share their experiences, or to simply listen and learn.

The Latest

Featured

EO Care Appoints William Fleming and Kristi Savacool to Board of Directors

EO Data & Methodology: November 2025 Update

EO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data

Living with Chronic Pain

Meet eo: the Future of Cannabis Care

Ingredients for Effective Care

Community & Cannabis

Gaps in Guidance

CBD & Gastrointestinal Pain

Cannabinoids & Pain Control

Cannabis & Sleeplessness

CB2 as a Regulator of Anxiety & Potential Target for PTSD Drugs

The Pros & Cons of Vaporization

What Is The Entourage Effect?

Cannabis and Men's Health: A CED Clinic Live Webinar

EO in Your Inbox